Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Grand View Research | PRODUCT CODE: 1404790

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1404790

Next-generation Sequencing Services Market Size, Share & Trends Analysis Report By Service Type (Human Genome Sequencing, Gene Regulation Services), By Workflow, By End-use, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Next-generation Sequencing Services Market Growth & Trends:

The global next-generation sequencing services market size is expected to reach USD 24.48 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.68% from 2024 to 2030. The development of next-generation sequencing (NGS) technologies has revolutionized gene sequencing in terms of reproducibility and cost savings. This has resulted in the introduction of several advancements in NGS technology to promote its usage in clinical labs and hospitals. Most current innovations in this field revolve around simplifying the usage of seq-technology and making it more sophisticated. These factors have driven the uptake of NGS services across various end-users.

Next-generation sequencing has progressed from research to clinical use in the last five years. Around 14 nations have launched large-scale genome sequencing programs, with nearly 60 million people expected to have their genome analyzed by 2025. Conventional disease testing service providers have broadened their portfolio with a rising trend of seq-based genetic tests. For instance, ARUP Laboratories announced the release of new coronavirus tests in March 2022, and IDbyDNA, Inc. partnered with another firm to introduce new coronavirus tests, an NGS test for respiratory illnesses, to aid physicians in evaluating patients with pneumonia and some other respiratory problems.

With the rising trend of high throughput sequencing within the pharma and biotech industry, there is a need for more developments to improve the speed and convenience of high throughput seq-platforms and simplify workflows. As a result, companies are focusing on the development of solutions to simplify the amplification and purification of samples and starting input. In March 2022, Illumina, Inc. announced the release of TruSigh Oncology (TSO) Comprehensive (EU), a comprehensive diagnostic that evaluates several tumor genes and indicators to identify a patient's cancer's individual molecular profile. The in vitro diagnostic (IVD) kit would assist in influencing genomic decisions for patients with cancer across Europe, with its global debut taking place first in Europe.

Next-generation Sequencing Services Market Report Highlights:

  • By service type, human genome sequencing held the largest revenue share in 2023 owing to greater penetration of whole genome and whole exome sequencing
  • Gene regulation services, particularly small RNA sequencing and ChIP-seq, are anticipated to grow at a lucrative pace during the forecast period. Rising investment in RNA sequencing is fueling the growth of gene regulation services
  • The larger revenue share of sequencing services as compared to other workflow steps can be attributed to an increase in the installation of sequencing platforms. High maintenance and recovery costs of this step have also resulted in greater revenue generation
  • By end-use, the universities and other research entities segment held the largest revenue share in 2023 owing to the growing application of NGS technology for cancer prognosis as well as diagnosis and major projects taken up by academicians and universities
  • North America dominated the market in 2023 owing to higher penetration of the technology in this region and the availability of funds to employ the technique and derive research findings for disease targeting
  • Companies such as GENEWIZ and Novogene Corporation are engaged in offering NGS services based on platforms from major NGS developers. Companies such as Illumina and BGI, on the other hand, are involved in developing sequencing instruments and offering services to research entities
  • In November 2021, Novogene stated during the 44th Annual Gathering of Molecular Biological Society of Japan (MSBJ) in Japan that they will be launching single-cell sequencing services specifically for their Japanese customers
  • GENEWIZ scientists are assisting in identifying the NGS solution for the projects. The NeXT Dx Test was launched by Personalis, Inc. to assist oncologists in identifying new therapy and clinical trial choices for cancer patients
Show more
Product Code: GVR-2-68038-630-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information analysis
    • 1.2.2. Market formulation & data visualization
    • 1.2.3. Data validation & publishing
  • 1.3. Information Procurement
    • 1.3.1. Primary Others
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Market Model
  • 1.7. Objectives
    • 1.7.1. Objective 1
    • 1.7.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Decline in sequencing prices
    • 3.3.2. Growing awareness pertaining to women & reproductive health
    • 3.3.3. Strategies undertaken for implementation of clinical NGS
  • 3.4. Market Restraint Analysis
    • 3.4.1. Challenges pertaining to implementation of large-scale NGS analysis workflows
    • 3.4.2. Analytical challenges in single cell sequencing
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Service Type Business Analysis

  • 4.1. Global Next Generation Sequencing Services Market: Service Type Movement Analysis
  • 4.2. Human Genome Sequencing Services
    • 4.2.1. Human Genome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.3. Single-Cell Sequencing Services
    • 4.3.1. Single-Cell Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.4. Microbial Genome-based Sequencing Services
    • 4.4.1. Microbial Genome-based Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.5. Gene Regulation Services
    • 4.5.1. Gene Regulation Services Market, 2018 - 2030 (USD Million)
    • 4.5.2. Small RNA Sequencing Services
      • 4.5.2.1. Small RNA Sequencing Services Market, 2018 - 2030 (USD Million)
    • 4.5.3. Chip Sequencing Services
      • 4.5.3.1. Chip Sequencing Services Market, 2018 - 2030 (USD Million)
    • 4.5.4. Other Gene Regulation-based Service
      • 4.5.4.1. Other Gene Regulation-based Service Market, 2018 - 2030 (USD Million)
  • 4.6. Animal & Plant Sequencing Services
    • 4.6.1. Animal & Plant Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.7. Other Sequencing Services
    • 4.7.1. Other Sequencing Services Market, 2018 - 2030 (USD Million)

Chapter 5. Workflow Business Analysis

  • 5.1. Global Next Generation Sequencing Services market: Workflow Movement Analysis
  • 5.2. Pre Sequencing Service
    • 5.2.1. Pre Sequencing Service Market, 2018 - 2030 (USD Million)
  • 5.3. Sequencing Service
    • 5.3.1. Sequencing Service Market, 2018 - 2030 (USD Million)
  • 5.4. Data Analysis Service
    • 5.4.1. Data Analysis Service Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Global Next Generation Sequencing Services Market: End-use Movement Analysis
  • 6.2. Universities & Other Research Entities
    • 6.2.1. Universities & Other Research Entities Market, 2018 - 2030 (USD Million)
  • 6.3. Hospitals & Clinics
    • 6.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 6.4. Pharma & Biotech Entities
    • 6.4.1. Pharma & Biotech Entities Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Global Next generation sequencing services market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Target Disease Prevalence
      • 7.2.2.5. U.S. Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Target Disease Prevalence
      • 7.2.3.5. Canada Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Target Disease Prevalence
      • 7.3.2.5. Germany Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Target Disease Prevalence
      • 7.3.3.5. UK Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Target Disease Prevalence
      • 7.3.4.5. France Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Target Disease Prevalence
      • 7.3.5.5. Italy Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Target Disease Prevalence
      • 7.3.6.5. Spain Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Target Disease Prevalence
      • 7.3.7.5. Denmark Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Target Disease Prevalence
      • 7.3.8.5. Sweden Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Target Disease Prevalence
      • 7.3.9.5. Norway Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.10. Switzerland
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Competitive Scenario
      • 7.3.10.3. Regulatory Framework
      • 7.3.10.4. Target Disease Prevalence
      • 7.3.10.5. Switzerland Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Target Disease Prevalence
      • 7.4.2.5. Japan Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Target Disease Prevalence
      • 7.4.3.5. China Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Target Disease Prevalence
      • 7.4.4.5. India Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Target Disease Prevalence
      • 7.4.5.5. South Korea Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Target Disease Prevalence
      • 7.4.6.5. Australia Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Target Disease Prevalence
      • 7.4.7.5. Thailand Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.8. Singapore
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Target Disease Prevalence
      • 7.4.8.5. Singapore Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Target Disease Prevalence
      • 7.5.2.5. Brazil Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Target Disease Prevalence
      • 7.5.3.5. Mexico Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Target Disease Prevalence
      • 7.5.4.5. Argentina Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Target Disease Prevalence
      • 7.6.2.5. South Africa Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Target Disease Prevalence
      • 7.6.3.5. Saudi Arabia Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Target Disease Prevalence
      • 7.6.4.5. UAE Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Target Disease Prevalence
      • 7.6.5.5. Kuwait Next generation sequencing services market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market/Position Share Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Quest Diagnostics Incorporated
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. ARUP Laboratories
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Applied Biological Materials, Inc. (abm)
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Novogene Co, Ltd.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Azenta Life Sciences (GENEWIZ)
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. NanoString
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Illumina, Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. PacBio
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Veritas
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. BGI (Beijing Genomics Institute)
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Gene by Gene Ltd.
      • 8.4.11.1. Overview
      • 8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. Lucigen Corporation
      • 8.4.12.1. Overview
      • 8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Strategic Initiatives
Show more
Product Code: GVR-2-68038-630-1

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global next generation sequencing services market by service type, 2018 - 2030 (USD Million)
  • Table 4 Global next generation sequencing services market by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global next generation sequencing services market by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 7 North America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 8 North America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 9 North America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 10 U.S. next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 11 U.S. next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 12 U.S. next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 14 Canada next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 15 Canada next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Europe next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 17 Europe next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 18 Europe next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 20 Germany next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 21 Germany next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Germany next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 23 UK next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 24 UK next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 25 UK next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 26 France next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 27 France next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 28 France next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Italy next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 30 Italy next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 31 Italy next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Spain next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 33 Spain next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 34 Spain next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Denmark next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 36 Denmark next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 37 Denmark next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Sweden next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 39 Sweden next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 40 Sweden next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Norway next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 42 Norway next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 43 Norway next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Switzerland next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 45 Switzerland next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 46 Switzerland next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 51 Japan next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 52 Japan next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 53 Japan next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 54 China next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 55 China next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 56 China next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 57 India next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 58 India next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 59 India next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Australia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 61 Australia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 62 Australia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 63 South Korea next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 64 South Korea next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 65 South Korea next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Thailand next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 67 Thailand next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 68 Thailand next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Singapore next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 70 Singapore next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 71 Singapore next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Latin America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 73 Latin America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 74 Latin America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Latin America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 76 Brazil next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 77 Brazil next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 78 Brazil next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Mexico next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 80 Mexico next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 81 Mexico next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Argentina next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 83 Argentina next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 84 Argentina next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 85 MEA next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 86 MEA next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 87 MEA next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 88 MEA next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 89 South Africa next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 90 South Africa next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 91 South Africa next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 95 UAE next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 96 UAE next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 97 UAE next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 98 Kuwait next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 99 Kuwait next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 100 Kuwait next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 101 Participant's Overview
  • Table 102 Financial Performance
  • Table 103 Key Companies Undergoing Expansions
  • Table 104 Key Companies Undergoing Acquisitions
  • Table 105 Key Companies Undergoing Collaborations
  • Table 106 Key Companies Launching New Products/Services
  • Table 107 Key Companies Undergoing Partnerships
  • Table 108 Key Companies Undertaking Other Strategies

List of Figures

  • Fig. 1 Market Others process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary Others pattern
  • Fig. 4 Market Others approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2023 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Porter's analysis
  • Fig. 14 SWOT analysis
  • Fig. 15 Next-generation sequencing services market: Service type outlook and key takeaways
  • Fig. 16 Next-generation sequencing services market: Service type movement analysis
  • Fig. 17 Human genome sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Single-cell sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Microbial genome-based sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Gene regulation services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Small RNA sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Chip sequencing service market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Other gene regulation-based service market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Animal & plant sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Other sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Next-generation sequencing services market: Workflow outlook and key takeaways
  • Fig. 27 Next generation sequencing services market: Workflow movement analysis
  • Fig. 28 Pre sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Data analysis service market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Next-generation sequencing services market: End-use outlook and key takeaways
  • Fig. 32 Next-generation sequencing services market: End-use movement analysis
  • Fig. 33 Universities & other research entities, 2018 - 2030 (USD Million)
  • Fig. 34 Hospitals & clinics, 2018 - 2030 (USD Million)
  • Fig. 35 Pharma & biotech entities, 2018 - 2030 (USD Million)
  • Fig. 36 Other end-use, 2018 - 2030 (USD Million)
  • Fig. 37 Global next generation sequencing services market: Regional outlook and key takeaways
  • Fig. 38 North America next generation sequencing services market, 2018 - 2030 (USD million)
  • Fig. 39 US key country dynamics
  • Fig. 40 US next generation sequencing services market, 2018 - 2030 (USD million)
  • Fig. 41 Canada key country dynamics
  • Fig. 42 Canada next generation sequencing services market, 2018 - 2030 (USD million)
  • Fig. 43 Europe next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 44 Germany key country dynamics
  • Fig. 45 Germany next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 46 France key country dynamics
  • Fig. 47 France next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 48 UK key country dynamics
  • Fig. 49 UK next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 50 Italy key country dynamics
  • Fig. 51 Italy next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 52 Spain key country dynamics
  • Fig. 53 Spain next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 54 Denmark key country dynamics
  • Fig. 55 Denmark next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 56 Sweden key country dynamics
  • Fig. 57 Sweden next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 58 Norway key country dynamics
  • Fig. 59 Norway next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 60 Switzerland key country dynamics
  • Fig. 61 Switzerland next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 62 Asia-Pacific next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 63 China key country dynamics
  • Fig. 64 China next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 65 India key country dynamics
  • Fig. 66 India next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 67 South Korea key country dynamics
  • Fig. 68 South Korea next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 69 Japan key country dynamics
  • Fig. 70 Japan next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 71 Australia key country dynamics
  • Fig. 72 Australia next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 73 Thailand key country dynamics
  • Fig. 74 Thailand next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 75 Singapore key country dynamics
  • Fig. 76 Singopore next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 77 Latin America next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 78 Brazil key country dynamics
  • Fig. 79 Brazil next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 80 Mexico key country dynamics
  • Fig. 81 Mexico next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 82 Argentina key country dynamics
  • Fig. 83 Argentina next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 84 MEA next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 85 South Africa key country dynamics
  • Fig. 86 South Africa next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 87 Saudi Arabia key country dynamics
  • Fig. 88 Saudi Arabia next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 89 UAE key country dynamics
  • Fig. 90 UAE next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 91 Kuwait key country dynamics
  • Fig. 92 Kuwait next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 93 Market participant categorization
  • Fig. 94 Next generation sequencing services market share analysis, 2023
  • Fig. 95 Strategy framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!